| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b755982699e3ea5199d569ee5f5344c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8183a288e80d3d5e49e470eef09d228
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139d0f1a10aaa0b44ab48cd7445f41ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d7a7586126f18b4a8d1ee298bb4fbe1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_179da1d7c274a9b5dd9a1b568f7e9818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2bf758867e279b687f0997d35e48c9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be7a0e2c69f3096432e9bda3cc2f9fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a96b73252badc35491c80ab5cebe6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f217a3300432a28eed9b13f17d8d24a |
| publicationDate |
2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201139440-A |
| titleOfInvention |
Compounds for treating neurodegenerative diseases |
| abstract |
The invention provides novel spirotetrahydronaphthalene compounds of Formula α that inhibit β -secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases. |
| priorityDate |
2010-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |